Impact of Opiate abuse on HIV-mediated Pulmonary Vascular Remodeling
阿片类药物滥用对 HIV 介导的肺血管重塑的影响
基本信息
- 批准号:9204520
- 负责人:
- 金额:$ 51.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcquired Immunodeficiency SyndromeAdultAntioxidantsApoptosisApoptoticArterial DisorderAutophagocytosisAutophagosomeBasic ScienceBlood VesselsCardiopulmonaryCardiovascular systemCellsChildCocaineComplementComplexDevelopmentDiagnosisDiseaseDrug abuseEndothelial CellsExcisionExposure toGene ExpressionGenesGenetic TranscriptionGoalsHIVHIV InfectionsHIV-1HealthHeartHematological DiseaseHeroinHumanIllicit DrugsImmunologic Deficiency SyndromesIn VitroIncidenceIndividualInterventionInvestigationLesionLesion by StageLinkLungMacacaMediatingMitochondriaMolecularMorbidity - disease rateMorphineNaloxoneNarcotic AntagonistsOpioidOrganellesOxidative StressPathogenesisPatientsPrevalenceProliferatingProteinsPulmonary vesselsRattusRegulationReportingResearchResistanceRisk FactorsRoleSIVSeveritiesSignal TransductionSourceStagingStructure of parenchyma of lungTestingTherapeutic InterventionTrans-ActivatorsTransgenic OrganismsUnited StatesVascular DiseasesVascular Endothelial CellVascular remodelingViralViral ProteinsVirusantiretroviral therapyattenuationbasecytotoxicdrug of abuseimprovedin vivoinhibitor/antagonistinnovationintravenous drug useintravenous drug userknock-downmortalitynon-drugnovelnovel therapeuticsopioid abusepreventpulmonary arterial hypertension
项目摘要
Project Summary
Improved survival among human immuno-deficiency virus (HIV-1) infected individuals with the advent of
antiretroviral therapy has clearly led to serious increase in the prevalence of noninfectious complications. In
this regard, one of the most devastating sequelae is the development of pulmonary arterial hypertension in
HIV-infected individuals (HPAH). Intravenous drug use (IVDU) accounts for one-third of all new cases of AIDS
in the United States and has been identified as the most common risk factor in the individuals diagnosed with
HPAH. Our recent findings showing enhanced pulmonary vascular remodeling in HIV-infected lung tissues
from IV heroin and/or cocaine abusers and in -infected macaques exposed to
morphine indicate that illicit drugs and HIV-1 potentially act in concert to cause pulmonary arteriopathy.
Furthermore, SIV-infected morphine treated macaques were found to have increased number of apoptotic
endothelial cells in the early stage lesions, whereas complete occlusion by actively proliferating endothelial
simian immunodeficiency (SIV)
cells was observed in the advanced stage plexiform lesions.
This observation was further supported by our in-
vitro findings showing enhanced apoptosis followed by significantly increased proliferation of human pulmonary
endothelial cells on simultaneous treatment with HIV-
transactivator of transcription
(Tat) protein and morphine
compared to either treatment alone. Based on our recent findings, the hypothesis of our study is that the
combined exposure of pulmonary endothelial cells to HIV-protein(s) and morphine results in the induction of
autophagy that leads to enhanced proliferation of endothelial cells and severe pulmonary vascular remodeling.
This hypothesis will be tested by pursuing three specific aims. In the first aim we will evaluate the effect of HIV-
Tat and morphine on the oxidative stress mediated regulation of bulk autophagy in endothelial cells. In the
second aim, we propose to delineate the role of autophagy/mitophagy in Tat and morphine mediated enhanced
proliferation. Third aim will be focused on in-vivo investigation of PAH and autophagy in HIV-1 Tg rats with or
without morphine exposure. These studies are innovative because to the best of our knowledge it will be the
first attempt to understand the potential link between the role of autophagy/mitophagy in the morphine and
HIV-proteins mediated apoptosis resistant enhanced proliferation. The proposed research will enhance our
understanding of the fundamental mechanisms involved in the pathogenesis of HPAH and therefore is directly
responsive to RFA-HL-14-024 (Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood
(HLB) Diseases in Adults and Children).
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Navneet Kaur Dhillon其他文献
Navneet Kaur Dhillon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Navneet Kaur Dhillon', 18)}}的其他基金
Drug abuse and HIV-associated pulmonary vascular injury
药物滥用和 HIV 相关肺血管损伤
- 批准号:
10330405 - 财政年份:2021
- 资助金额:
$ 51.4万 - 项目类别:
Drug abuse and HIV-associated pulmonary vascular injury
药物滥用和 HIV 相关肺血管损伤
- 批准号:
10799336 - 财政年份:2021
- 资助金额:
$ 51.4万 - 项目类别:
Drug abuse and HIV-associated pulmonary vascular injury
药物滥用和 HIV 相关肺血管损伤
- 批准号:
10161471 - 财政年份:2021
- 资助金额:
$ 51.4万 - 项目类别:
Drug abuse and HIV-associated pulmonary vascular injury
药物滥用和 HIV 相关肺血管损伤
- 批准号:
10539306 - 财政年份:2021
- 资助金额:
$ 51.4万 - 项目类别:
Extracellular Vesicles and and HIV/cocaine associated cardiopulmonary dysfunction
细胞外囊泡和 HIV/可卡因相关的心肺功能障碍
- 批准号:
9204218 - 财政年份:2016
- 资助金额:
$ 51.4万 - 项目类别:
Impact of Opiate abuse on HIV-mediated Pulmonary Vascular Remodeling
阿片类药物滥用对 HIV 介导的肺血管重塑的影响
- 批准号:
9115350 - 财政年份:2015
- 资助金额:
$ 51.4万 - 项目类别:
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.
HIV/可卡因介导的人肺血管重塑:BMPR 信号传导的作用。
- 批准号:
8508237 - 财政年份:2012
- 资助金额:
$ 51.4万 - 项目类别:
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.
HIV/可卡因介导的人肺血管重塑:BMPR 信号传导的作用。
- 批准号:
8410671 - 财政年份:2012
- 资助金额:
$ 51.4万 - 项目类别:
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.
HIV/可卡因介导的人肺血管重塑:BMPR 信号传导的作用。
- 批准号:
8653959 - 财政年份:2012
- 资助金额:
$ 51.4万 - 项目类别:
PDGF-Receptor regulation in Cocaine and Tat mediated Smooth Muscle Hyperplasia
可卡因和 Tat 介导的平滑肌增生中 PDGF 受体的调节
- 批准号:
8231329 - 财政年份:2011
- 资助金额:
$ 51.4万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 51.4万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 51.4万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 51.4万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 51.4万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 51.4万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 51.4万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 51.4万 - 项目类别:














{{item.name}}会员




